{"id":"NCT04842604","sponsor":"Pfizer","briefTitle":"Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML","officialTitle":"A MULTI-CENTER CONTINUATION STUDY EVALUATING AZACITIDINE WITH OR WITHOUT GLASDEGIB (PF-04449913) IN PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID LEUKEMIA, MYELODYSPLASTIC SYNDROME OR CHRONIC MYELOMONOCYTIC LEUKEMIA","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-05-17","primaryCompletion":"2022-12-02","completion":"2022-12-02","firstPosted":"2021-04-13","resultsPosted":"2023-12-18","lastUpdate":"2023-12-18"},"enrollment":14,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Myeloid Leukemia","Myelodysplastic Syndrome","Chronic Myelomonocytic Leukemia"],"interventions":[{"type":"DRUG","name":"Glasdegib","otherNames":["PF-04449913"]},{"type":"DRUG","name":"Azacitidine","otherNames":[]}],"arms":[{"label":"Participants from B1371019 and B1371012","type":"EXPERIMENTAL"}],"summary":"An open-label study available to all eligible participants from Study B1371019 and participants originating from Study B1371012 continuing on study intervention with azacitidine with or without glasdegib.","primaryOutcome":{"measure":"Number of Participants With Treatment Emergent Adverse Event (AE) and Treatment Related AE","timeFrame":"From initiation of study treatment to study completed from 17-May-2021 to 02-Dec-2022 (approximately 565 days)","effectByArm":[{"arm":"Glasdegib + Azacitidine","deltaMin":7,"sd":null},{"arm":"Placebo + Azacitidine","deltaMin":4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":18,"countries":["Austria","Canada","Czechia","France","Hungary","Italy","Japan","Mexico","Poland","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["https://clinicaltrials.gov/ct2/show/NCT03416179?term=B1371019&draw=2&rank=1"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":9},"commonTop":["Neutropenia","Anaemia","Thrombocytopenia","Retinal detachment","Colitis"]}}